Provided by Tiger Trade Technology Pte. Ltd.

Guardant Health Inc.

85.18
-3.9000-4.38%
Post-market: 86.841.66+1.95%19:59 EDT
Volume:2.40M
Turnover:205.41M
Market Cap:11.17B
PE:-25.65
High:89.11
Open:88.74
Low:84.42
Close:89.08
52wk High:120.74
52wk Low:36.36
Shares:131.17M
Float Shares:126.00M
Volume Ratio:1.50
T/O Rate:1.91%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.3203
EPS(LYR):-3.3203
ROE:-4584.47%
ROA:-15.59%
PB:-112.51
PE(LYR):-25.65

Loading ...

Guardant Health director Tariq Musa reports disposal of USD 30,660 in common shares

Reuters
·
Mar 20

Guardant Health to present 28 abstracts at AACR annual meeting

Reuters
·
Mar 18

Guardant Health CFO Michael Brian Bell disposes of USD 261,111 in common shares

Reuters
·
Mar 18

Bitdeer Launches SEALMINER DL1 Air: Achieving 149 J/GH Power Efficiency and 25 GH/s for Scrypt Mining

GlobeNewswire
·
Mar 16

BRIEF-Guardant Health Launches Shield Multi-Cancer Detection (Mcd) Test In Multiple Markets In Asia With Manulife Partnership

Reuters
·
Mar 16

Guardant Health Inc - Manulife Customers in Asia to Access Shield Mcd Test Beginning April 2026

THOMSON REUTERS
·
Mar 16

Is Guardant Health’s (GH) Shield Tour Redefining Its Competitive Moat in Cancer Screening?

Simply Wall St.
·
Mar 16

Manulife Announces Exclusive Partnership With Guardant Health to Bring the Shield Multi-Cancer Detection Test to Customers Across Asia

THOMSON REUTERS
·
Mar 16

Guardant Health survey shows 92% support no-copay coverage for colorectal cancer blood tests

Reuters
·
Mar 13

Braidwell, Karnal and Kreiter's AI healthcare fund, surged 28% last year

Reuters
·
Mar 11

GH Research price target raised to $34 from $29 at Guggenheim

TIPRANKS
·
Mar 10

Analysts Offer Insights on Healthcare Companies: GH Research (GHRS) and Sionna Therapeutics, Inc. (SION)

TIPRANKS
·
Mar 07

GH Research Is Maintained at Buy by Needham

Dow Jones
·
Mar 06

Stifel Nicolaus Sticks to Their Buy Rating for GH Research (GHRS)

TIPRANKS
·
Mar 06

Canaccord Genuity Reaffirms Their Buy Rating on GH Research (GHRS)

TIPRANKS
·
Mar 06

Guardant Health CIO Kumud Kalia Disposes of Common Shares

Reuters
·
Mar 06

GH Research's 2025 Net Loss Widens

MT Newswires Live
·
Mar 05

GH Research Q4 EPS $(0.23) Beats $(0.28) Estimate

Benzinga
·
Mar 05

Press Release: GH Research Reports Full Year 2025 Financial Results and Provides Business Update

Dow Jones
·
Mar 05

Analysts Offer Insights on Healthcare Companies: Guardant Health (GH) and 908 Devices (MASS)

TIPRANKS
·
Mar 04